These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21426158)

  • 1. Therapeutic implications of new insights into the critical role of VP16 in initiating the earliest stages of HSV reactivation from latency.
    Thompson RL; Sawtell NM
    Future Med Chem; 2010 Jul; 2(7):1099-105. PubMed ID: 21426158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can HSV latency be conquered by current antiviral therapies?
    Simmons A; Field HJ
    Sex Transm Infect; 1998 Feb; 74(1):1-2. PubMed ID: 9634293
    [No Abstract]   [Full Text] [Related]  

  • 3. [Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis].
    Shimomura Y
    Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):247-64; discussion 265. PubMed ID: 18411713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonizing the Glucocorticoid Receptor Impairs Explant-Induced Reactivation in Mice Latently Infected with Herpes Simplex Virus 1.
    Harrison KS; Zhu L; Thunuguntla P; Jones C
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30971470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex virus latency and nucleoside analogues.
    Efstathiou S; Field HJ; Griffiths PD; Kern ER; Sacks SL; Sawtell NM; Stanberry LR
    Antiviral Res; 1999 Apr; 41(3):85-100. PubMed ID: 10320042
    [No Abstract]   [Full Text] [Related]  

  • 6. Herpes simplex virus latency after direct ganglion virus inoculation.
    Hay KA; Edris WA; Gaydos A; Tenser RB
    J Neurovirol; 1998 Oct; 4(5):531-8. PubMed ID: 9839650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of a host-targeted antiviral that abrogates herpes simplex virus replication through modulation of arginine-associated metabolic pathways.
    Sanchez MD; Ochoa AC; Foster TP
    Antiviral Res; 2016 Aug; 132():13-25. PubMed ID: 27192555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new promising candidate to overcome drug resistant herpes simplex virus infections.
    Zinser E; Krawczyk A; Mühl-Zürbes P; Aufderhorst U; Draßner C; Stich L; Zaja M; Strobl S; Steinkasserer A; Heilingloh CS
    Antiviral Res; 2018 Jan; 149():202-210. PubMed ID: 29155164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VP16 serine 375 is a critical determinant of herpes simplex virus exit from latency in vivo.
    Sawtell NM; Triezenberg SJ; Thompson RL
    J Neurovirol; 2011 Dec; 17(6):546-51. PubMed ID: 22144074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the Super Elongation Complex Suppresses Herpes Simplex Virus Immediate Early Gene Expression, Lytic Infection, and Reactivation from Latency.
    Alfonso-Dunn R; Arbuckle JH; Vogel JL; Kristie TM
    mBio; 2020 Jun; 11(3):. PubMed ID: 32518191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex virus type-1: replication, latency, reactivation and its antiviral targets.
    Pires de Mello CP; Bloom DC; Paixão IC
    Antivir Ther; 2016; 21(4):277-86. PubMed ID: 26726828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The US11 Gene of Herpes Simplex Virus 1 Promotes Neuroinvasion and Periocular Replication following Corneal Infection.
    Charron AJ; Ward SL; North BJ; Ceron S; Leib DA
    J Virol; 2019 May; 93(9):. PubMed ID: 30760571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of HSV Viral Reactivation in Explants of Sensory Neurons.
    Arbuckle JH; Turner AM; Kristie TM
    Curr Protoc Microbiol; 2014 Nov; 35():14E.6.1-21. PubMed ID: 25367271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes simplex encephalitis : from virus to therapy.
    Rozenberg F; Deback C; Agut H
    Infect Disord Drug Targets; 2011 Jun; 11(3):235-50. PubMed ID: 21488834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.
    Davido DJ; Tu EM; Wang H; Korom M; Gazquez Casals A; Reddy PJ; Mostafa HH; Combs B; Haenchen SD; Morrison LA
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29950407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide inhibitors against herpes simplex virus infections.
    Galdiero S; Falanga A; Tarallo R; Russo L; Galdiero E; Cantisani M; Morelli G; Galdiero M
    J Pept Sci; 2013 Mar; 19(3):148-58. PubMed ID: 23389903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of famciclovir on herpes simplex virus type 1 corneal disease and establishment of latency in rabbits.
    Loutsch JM; Sainz B; Marquart ME; Zheng X; Kesavan P; Higaki S; Hill JM; Tal-Singer R
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2044-53. PubMed ID: 11408221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel selective LSD1/KDM1A inhibitor epigenetically blocks herpes simplex virus lytic replication and reactivation from latency.
    Liang Y; Quenelle D; Vogel JL; Mascaro C; Ortega A; Kristie TM
    mBio; 2013 Feb; 4(1):e00558-12. PubMed ID: 23386436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alphaherpesvirus Latency and Reactivation with a Focus on Herpes Simplex Virus.
    Sawtell NM; Thompson RL
    Curr Issues Mol Biol; 2021; 41():267-356. PubMed ID: 32883886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lund Human Mesencephalic (LUHMES) Neuronal Cell Line Supports Herpes Simplex Virus 1 Latency
    Edwards TG; Bloom DC
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30602607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.